Asymmetrex Sponsors Podcast on "Counting Stem Cells for a New Era of Medicine"
BOSTON (PRWEB) November 06, 2019
In October, Massachusetts stem cell biotechnology company Asymmetrex launched a new podcast to provide information to patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical practice, stem cell treatments are given without knowing the dose of the treating stem cells. This problem affects all patients receiving stem cell treatments, including patients receiving approved treatments in routine clinical practice, patients volunteering for experimental treatments in FDA-authorized clinical trials, and patients obtaining unapproved treatments in private stem cell clinics.
The costs and dangers of unknown stem cell dose in treatments are significant. Stem cell clinical trials cannot be interpreted without knowing the treatment dose, leading to huge wastes of both federal and private clinical research dollars. In the case of manufactured stem cells, many treatments may contain very few or no stem cells at all. It is impossible for doctors to improve treatments without knowing the stem cell dose. Stem cell donors for approved treatments like blood stem cell transplantation are scarce. Knowing the stem cell dose would allow doctors to know when a treatment sample has enough stem cells to treat more than one patient; or when it does not have enough to treat even a single patient. In the second case, not knowing the stem cell dose can result in the death of children treated for leukemia when unknowingly they receive an umbilical cord blood transplant with too few blood stem cells to save them.
Earlier this year, the FDA recognized the pressing need for stem cell dose in stem cell medicine. The agencys Standards Coordinating Body for Regenerative Medicine (SCB) listed stem cell dose determination as a priority for needed standards for stem cell medicine. Dose is a fundamental principle for the discovery, development, and administration of quality medicines. Asymmetrex Director James L. Sherley, M.D., Ph.D., who is featured in the new podcast, says that, Dose is essential for stem cell medicine as well. The new podcast has the goal of informing the end users of stem cell treatments: the patients, their doctors, their families, and their advocates, including the FDA. When the people most impacted by these treatments understand that knowing the dose of stem cells is just as important as knowing the dose of their other medicines, they will be empowered to demand this essential certification of the integrity of their stem cell treatments.
The first episode of the podcast, Counting Stem Cells For A New Era Of Medicine, aired online on October 17. The third episode of the biweekly, 6-episode series is scheduled for airing November 12. Each episode features an interview of Asymmetrex Director Sherley by podcast producer Jordan Rich. Mr. Rich guides Dr. Sherley through a discussion of questions that reveal the current challenges that Asymmetrex is addressing to achieve full adoption of stem cell dose as a routine practice in stem cell medicine. The series also highlights other significant applications for stem cell counting in drug development and environmental health science. In conjunction with this educational effort, the company is also sponsoring a study on its website to evaluate the current state of public, academic, and industry knowledge of coming changes in stem cell medicine related to the adoption of stem cell dose.
About Asymmetrex
Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrexs founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The companys patent portfolio contains biotechnologies that solve the two main technical problems production and quantification that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the AlphaSTEM Test) for use in stem cell transplantation therapies and pre-clinical drug evaluations.
Share article on social media or email:
See the rest here:
New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments - PR Web
- Mass. Law About Stem Cell Research - Massachusetts Trial ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Theres a New Anti-ALS Association Ice Bucket Challenge [Last Updated On: August 23rd, 2014] [Originally Added On: August 23rd, 2014]
- Expert: Catholic objections wont leave ALS fundraiser all wet [Last Updated On: August 23rd, 2014] [Originally Added On: August 23rd, 2014]
- Gene expression patterns in pancreatic circulating tumor cells revealed [Last Updated On: September 24th, 2014] [Originally Added On: September 24th, 2014]
- Inner Cell Mass - Embryonic Development & Stem Cells ... [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Mass production of placenta stem cells gets FDA approval ... [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Siamab Therapeutics Appoints Robert Mashal to Board of Directors [Last Updated On: October 9th, 2014] [Originally Added On: October 9th, 2014]
- Brain Tumor Stem Cell Lab - Massachusetts General Hospital ... [Last Updated On: October 9th, 2014] [Originally Added On: October 9th, 2014]
- 107.23 /$ (5 p.m.) [Last Updated On: October 15th, 2014] [Originally Added On: October 15th, 2014]
- Stem Cell Eye Treatment May Restore Vision [Last Updated On: October 16th, 2014] [Originally Added On: October 16th, 2014]
- Scientists Engineer Cancer-Killing Stem Cells [Last Updated On: October 26th, 2014] [Originally Added On: October 26th, 2014]
- Stem Cell Therapy, Stem Cell Biology at Mass General Hospital [Last Updated On: October 31st, 2014] [Originally Added On: October 31st, 2014]
- Harvard researchers genetically 'edit' human blood stem cells [Last Updated On: November 6th, 2014] [Originally Added On: November 6th, 2014]
- Human blood stem cells genetically 'edited' [Last Updated On: November 7th, 2014] [Originally Added On: November 7th, 2014]
- Critical Mass of Stem Cells Sets Off Embryonic Development ... [Last Updated On: November 12th, 2014] [Originally Added On: November 12th, 2014]
- Reprogramming cells, long term [Last Updated On: November 18th, 2014] [Originally Added On: November 18th, 2014]
- Pain and itch neurons grown in a dish [Last Updated On: November 25th, 2014] [Originally Added On: November 25th, 2014]
- Blood test could pick up risk of cancer five years in advance, say Harvard scientists [Last Updated On: November 28th, 2014] [Originally Added On: November 28th, 2014]
- The obesity pill that could replace exercise by turning 'bad' fat to 'good' [Last Updated On: December 9th, 2014] [Originally Added On: December 9th, 2014]
- Stem cells: The black box of reprogramming [Last Updated On: December 11th, 2014] [Originally Added On: December 11th, 2014]
- Canadian scientists crack stem cell reprogramming code [Last Updated On: December 11th, 2014] [Originally Added On: December 11th, 2014]
- Proteins drive cancer cells to change states [Last Updated On: December 16th, 2014] [Originally Added On: December 16th, 2014]
- Massachusetts (Stem Cell) - what-when-how [Last Updated On: February 3rd, 2015] [Originally Added On: February 3rd, 2015]
- New Organ Liver Prize Gathers Momentum [Last Updated On: February 4th, 2015] [Originally Added On: February 4th, 2015]
- MIT researchers develop glucose-responsive diabetes treatment [Last Updated On: February 11th, 2015] [Originally Added On: February 11th, 2015]
- Scientists develop novel technique for finding drugs to combat malaria [Last Updated On: February 11th, 2015] [Originally Added On: February 11th, 2015]
- Could we soon have man-made blood? [Last Updated On: March 10th, 2015] [Originally Added On: March 10th, 2015]
- Protein that repels immune cells protects transplanted pancreatic islets from rejection [Last Updated On: March 10th, 2015] [Originally Added On: March 10th, 2015]
- Researchers identify a vital protein that can determine head and brain development [Last Updated On: March 13th, 2015] [Originally Added On: March 13th, 2015]
- Biomedical engineer developing nanomaterial for healing broken bones [Last Updated On: March 18th, 2015] [Originally Added On: March 18th, 2015]
- Scientists engineer toxin-secreting stem cells to treat ... [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Cloning/Embryonic Stem Cells - Genome.gov [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Stem Cell Facts - University of Massachusetts Medical School [Last Updated On: July 27th, 2016] [Originally Added On: July 27th, 2016]
- Stem Cell FAQ - Massachusetts General Hospital, Boston, MA [Last Updated On: July 27th, 2016] [Originally Added On: July 27th, 2016]
- Stem-cell-based therapy promising for treatment of breast ... [Last Updated On: September 26th, 2016] [Originally Added On: September 26th, 2016]
- What Are Stem Cells? - Massachusetts General Hospital ... [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- New England Cord Blood Bank - Cord Blood and Cord Tissue ... [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- Stem cell controversy - Wikipedia [Last Updated On: December 1st, 2016] [Originally Added On: December 1st, 2016]
- From Stem Cells to Human Development - September 2016 ... [Last Updated On: December 4th, 2016] [Originally Added On: December 4th, 2016]
- X4 joins hands with Yale on rare disease program - FierceBiotech [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- TGF-1: ALS Astrocytes' Secret Sauce? - ALS Research Forum [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- CRISPR fixes disease gene in viable human embryos - Nature.com [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- Current humanized mice not good models for studying stem cell transplants, say researchers - Scope (blog) [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- Mouse Model of Human Immune System Inadequate for Stem Cell ... - Technology Networks [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- ORGANOID - Science Magazine [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- Asymmetrex Introduces New Contract Service For Producing ... - PR Web (press release) [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- For Lowell native, stem cell match becomes a match as friends - Lowell Sun [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Lymphoma Patient's Brain Tumor Disappeared After She Received JCAR017, Study Reports - Lymphoma News Today [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Alternate Methods for Preparing Pluripotent Stem Cells ... [Last Updated On: September 25th, 2017] [Originally Added On: September 25th, 2017]
- Cloning/Embryonic Stem Cells - National Human Genome ... [Last Updated On: July 5th, 2018] [Originally Added On: July 5th, 2018]
- Boston, MA, Stem Cell Transplant, Weston, Nantucket ... [Last Updated On: January 10th, 2019] [Originally Added On: January 10th, 2019]
- Chronic variable stress activates hematopoietic stem cells ... [Last Updated On: April 12th, 2019] [Originally Added On: April 12th, 2019]
- Massachusetts Stem Cells | Stem Cell TV [Last Updated On: September 10th, 2019] [Originally Added On: September 10th, 2019]
- Comparison of Merus N.V. (MRUS) and Sage Therapeutics Inc. (NASDAQ:SAGE) - MS Wkly [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- Reviewing Cellectis S.A. (CLLS)'s and Magenta Therapeutics Inc. (NASDAQ:MGTA)'s results - MS Wkly [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- New study reveals why breast cancer spreads to the brain - USC News [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- Arkuda bags $44M to target progranulin and head off inherited dementia - FierceBiotech [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Exercise found to block chronic inflammation in mice - Harvard Gazette [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Top Emerging Technologies of the Year - Technowize [Last Updated On: December 29th, 2019] [Originally Added On: December 29th, 2019]
- Firm adds a new wrinkle to anti-aging products - Williamson Daily News [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018 - BioSpace [Last Updated On: January 10th, 2020] [Originally Added On: January 10th, 2020]
- 10 Of The Biggest World Revelations In The 21st Century - World Atlas [Last Updated On: February 29th, 2020] [Originally Added On: February 29th, 2020]
- Infrared Laser Treatment of TBI, PTSD, and Depression: An Expert Perspective - Psychiatry Advisor [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Startup targets glioblastoma tumors with CAR-T therapy - FierceBiotech [Last Updated On: May 28th, 2020] [Originally Added On: May 28th, 2020]
- Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder - Newswise [Last Updated On: July 2nd, 2020] [Originally Added On: July 2nd, 2020]
- Targeted Therapy for Non-Hodgkin Lymphoma: Current Progress and Future Plans - Cancer Therapy Advisor [Last Updated On: September 5th, 2020] [Originally Added On: September 5th, 2020]
- Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech [Last Updated On: October 24th, 2020] [Originally Added On: October 24th, 2020]
- NurOwn May Be Given to Early ALS Patients in US Who Finished Phase... - ALS News Today [Last Updated On: December 20th, 2020] [Originally Added On: December 20th, 2020]
- Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium - GlobeNewswire [Last Updated On: February 1st, 2021] [Originally Added On: February 1st, 2021]
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily [Last Updated On: February 1st, 2021] [Originally Added On: February 1st, 2021]
- On systemic sources of early life stress, and empathetic responses - MIT News [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting - PRNewswire [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- Infertility: Men account for at least half of cases. So why have women shouldered the blame? - The Irish Times [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- cGVHD Paradigm Gains Systemic Options Beyond Steroids, But Real-World Data Are Required - OncLive [Last Updated On: October 28th, 2021] [Originally Added On: October 28th, 2021]
- Stem cells: Sources, types, and uses - Medical News Today [Last Updated On: December 24th, 2021] [Originally Added On: December 24th, 2021]
- Liso-Cel Outperforms Standard Therapy in Improving QoL in Relapsed/Refractory LBCL - www.oncnursingnews.com/ [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]
- January 2022: 2021 Papers of the year - Environmental Factor Newsletter [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]
- MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults... [Last Updated On: March 25th, 2022] [Originally Added On: March 25th, 2022]
- Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners - The New York Academy of Sciences [Last Updated On: April 6th, 2022] [Originally Added On: April 6th, 2022]